Literature DB >> 19891736

The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

Harald H Sitte1, Michael Freissmuth.   

Abstract

Sodium-chloride coupled neurotransmitter transporters achieve reuptake of their physiological substrate by exploiting the pre-existing sodium-gradient across the cellular membrane. This terminates the action of previously released substrate in the synaptic cleft. However, a change of the transmembrane ionic gradients or specific binding of some psychostimulant drugs to these proteins, like amphetamine and its derivatives, induce reverse operation of neurotransmitter:sodium symporters. This effect eventually leads to an increase in the synaptic concentration of non-exocytotically released neurotransmitters [and - in the case of the norepinephrine transporters, underlies the well-known indirect sympathomimetic activity]. While this action has long been appreciated, the underlying mechanistic details have been surprisingly difficult to understand. Some aspects can be resolved by incorporating insights into the oligomeric nature of transporters, into the nature of the accompanying ion fluxes, and changes in protein kinase activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891736      PMCID: PMC4497806          DOI: 10.1111/j.1471-4159.2009.06474.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  167 in total

1.  Intracellular domains of a rat brain GABA transporter that govern transport.

Authors:  Nina Hansra; Shruti Arya; Michael W Quick
Journal:  J Neurosci       Date:  2004-04-21       Impact factor: 6.167

2.  The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

Authors:  Lei Shi; Matthias Quick; Yongfang Zhao; Harel Weinstein; Jonathan A Javitch
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

Review 3.  Listening to neurotransmitter transporters.

Authors:  H A Lester; Y Cao; S Mager
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

Review 4.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

5.  Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.

Authors:  S Ramamoorthy; R D Blakely
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

6.  Simple allosteric model for membrane pumps.

Authors:  O Jardetzky
Journal:  Nature       Date:  1966-08-27       Impact factor: 49.962

7.  Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells.

Authors:  Eugene V Mosharov; Liang-Wei Gong; Bhavanna Khanna; David Sulzer; Manfred Lindau
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

8.  Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.

Authors:  Cecilia T Giambalvo
Journal:  Synapse       Date:  2003-08       Impact factor: 2.562

9.  Ca2+-dependent and -independent release of neurotransmitters from PC12 cells: a role for protein kinase C activation?

Authors:  T Pozzan; G Gatti; N Dozio; L M Vicentini; J Meldolesi
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

10.  GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation.

Authors:  S Maier; V Reiterer; A M Ruggiero; J D Rothstein; S Thomas; R Dahm; H H Sitte; H Farhan
Journal:  J Cell Mol Med       Date:  2008-03-14       Impact factor: 5.310

View more
  43 in total

1.  The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Authors:  Michael H Baumann; Mario A Ayestas; John S Partilla; Jacqueline R Sink; Alexander T Shulgin; Paul F Daley; Simon D Brandt; Richard B Rothman; Arnold E Ruoho; Nicholas V Cozzi
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

Authors:  Samanta Yubero-Lahoz; Mario A Ayestas; Bruce E Blough; John S Partilla; Richard B Rothman; Rafael de la Torre; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2011-11-03       Impact factor: 4.432

3.  Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

Authors:  Hema Raina; Qingli Zhang; Albert Y Rhee; Thomas L Pallone; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

4.  Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters.

Authors:  Richard B Rothman; John S Partilla; Michael H Baumann; Catrissa Lightfoot-Siordia; Bruce E Blough
Journal:  J Pharmacol Exp Ther       Date:  2012-01-23       Impact factor: 4.030

5.  Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

Authors:  Mary Hongying Cheng; Luca Ponzoni; Tatiana Sorkina; Ji Young Lee; She Zhang; Alexander Sorkin; Ivet Bahar
Journal:  Neuropharmacology       Date:  2019-06-20       Impact factor: 5.250

Review 6.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

7.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

8.  [Researcher of the month].

Authors:  Thomas Steinkellner
Journal:  Wien Klin Wochenschr       Date:  2015-05       Impact factor: 1.704

9.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

10.  Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.

Authors:  Ali El-Kasaby; Herwig Just; Elisabeth Malle; Peggy C Stolt-Bergner; Harald H Sitte; Michael Freissmuth; Oliver Kudlacek
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.